Background：The proto-oncogene MET product is the hepatocyte growth factor receptor and encodes tyrosine-kinase activity. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor. Various mutations in the MET gene are associated with papillary renal carcinoma. Two transcript variants encoding different isoforms have been found for this gene.
仕様
Synonyms：AUTS9,c met,D249,Hepatocyte growth factor receptor,HGF,HGF receptor,HGF/SF receptor,HGFR,MET,Met proto oncogene tyrosine kinase,MET proto oncogene,receptor tyrosine kinase,Met proto-oncogene （hepatocyte growth factor receptor）,Met proto-oncogene,Met protooncogene,MET,Oncogene MET,Par4,Proto-oncogene c-Met,RCCP2,Scatter factor receptor,SF receptor,Tyrosine-protein kinase Met
Host：Rabbit
Reactivity：Human,Mouse,Rat
Applications：WB,IHC,ELISA
Concentration：0.5mg/mL
Immunogen：Synthetic peptide of human MET
Purification Method：Affinity purification
Clonality：Polyclonal
Conjugation：Unconjugated
Buffer：PBS with 0.05％ sodium azide, 50％ glycerol, PH7.3
